Market Overview​​​​​​
The Europe Laparoscopy devices market is US$ XX million in 2023 and is estimated to grow at a CAGR of XX% during the forecast period (2024-2031) to reach a value of US$ XX million in 2031.
Laparoscopic instruments are used along with a laparoscope, which is a thin telescope fitted with a cold light source and a video camera. Inert gases like carbon dioxide are used to inflate the abdominal region which increases the distance between the organs and the abdominal wall thus enlarging the operating field.
The Europe Laparoscopy devices are driven by various factors which includes, rise in the prevalence of chronic diseases, rise in minimal invasive procedures, advancements in the devices and others help the market to grow during the forecast period. The laparoscopic instruments market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include B. Braun AG, Johnson & Johnson (Ethicon Inc.), Karl Storz GmbH & Co.KG, Medtronic PLC. (Covidien), Olympus Corporation, Richard Wolf GmbH.
Market Dynamics
Drivers
Rise in the prevalence of colorectal cancer
The rising incidence of chronic diseases such as colorectal cancer has led to an increased demand for surgical interventions. Laparoscopic procedures are often preferred over traditional open surgeries due to their minimally invasive nature. Bowel cancer is the fourth most common cancer in the UK. Almost 43,000 people are diagnosed with bowel cancer every year in the UK. Around 268,000 people living in the UK today have been diagnosed with bowel cancer. More than nine out of ten new cases (94%) are diagnosed in people over 50. But bowel cancer can affect anyone of any age. More than 2,600 new cases are diagnosed in people under the age of 50 every year. 1 in 15 men and 1 in 18 women will be diagnosed with bowel cancer during their lifetime. According to Cancer Research UK, there could be around 47,700 new cases of bowel cancer every year in the UK by 2038-2040, projections suggest. Hence, the rise in chronic diseases like colorectal cancer indeed increases the demand for Laparoscopy devices which helps in the market growth during the forecast period.
Increasing adoption of minimally invasive surgeries over open surgeries
Laparoscopic procedures are less invasive and save costs in terms of pre- and post-operation care and the length of stay in hospitals. These surgeries result in less blood loss, fewer postoperative complications, and a shorter recovery time for patients. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. These factors have led to an increased preference for minimally invasive surgeries among patients. Around 15 million laparoscopic procedures are performed annually worldwide, and this number is estimated to grow significantly in the coming years. Laparoscopic colectomy, laparoscopic appendectomy, laparoscopic cholecystectomy, laparoscopic repair of inguinal hernia, laparoscopic hysterectomy, and laparoscopic bariatric surgeries hold a major share (approximately 40–45%) in the surgical procedures market. Traditional open surgeries involve long incisions made through the muscles, and these muscles take a considerable amount of time to heal, whereas MIS procedures involve smaller incisions, leading to a quicker recovery. These surgeries have been gaining wider acceptance among the geriatric population, due to the relatively shorter recovery time. Few organizations, such as the American Association of Gynecologic Laparoscopists (AAGL) and the International Society of Gynecologic Endoscopy (ISGE), have been collaborating with healthcare agencies in South Africa, to create awareness about the benefits of MIS, and improve the adoption rate.
Market Restraints
Gaps in infrastructure support for laparoscopic procedures in developing countries
Many developing nations face challenges in establishing and maintaining the necessary infrastructure for laparoscopic surgery. Insufficient access to advanced medical equipment, operating theaters, and sterilization facilities hinders the widespread implementation of this technique. Access to basic surgical procedures is a major challenge faced by developing countries. Countries such as India, South Korea, and Singapore are making efforts to improve their infrastructure by increasing the number of hospitals and training centers for providing continuing medical education in fields such as laparoscopic surgeries. However, there remains a wide gap in the infrastructure available in these developing countries to support advanced medical procedures, such as laparoscopy. Developing countries face the challenge of bridging the gap in terms of infrastructural support available for performing laparoscopic procedures. For instance, as many as 5 billion people, or two-thirds of the world’s population, lack access to surgical facilities. This restricts the number of laparoscopic procedures performed in these countries and poses a challenge for the laparoscopic instruments market.
Covid-19 Impact Analysis
The COVID-19 pandemic has had widespread effects on healthcare systems, including its impact on the Europe Laparoscopy devices market. During the COVID-19 pandemic, hospitals worldwide reduced elective and non-urgent cases to maintain social distancing and avoid transmission of the virus. However, urgent gynecological and cancer procedures were being performed, and it's critical that all theater staff be safeguarded, and the risk of SARS-CoV-2 viral transmission is minimized when operating on asymptomatic or diagnosed COVID-19 patients. The SARS-CoV-2 pandemic brings to attention a neglected subject in previous years, namely that of health risks related to exposure to plume and aerosolization during laparoscopy. Laparoscopic procedures have a theoretical risk of generating aerosols particularly during maintenance and evacuation of a pneumoperitoneum, CO2 leakage at the level of trocar orifices or changing instruments and while using energy devices due to smoke generation. The pandemic has disrupted supply chains of laproscopic instruments and raw materials in Europe. Manufacturers have faced challenges in sourcing components, maintaining production capacity and meeting increased demand, resulting in delays in product availability and distribution. Hence, the covid pandemic had a significant impact on the overall laprscopy devices market.
Segmentation Analysis
The market value for trocar systems is likely to reach USD XX million in 2031, from its recorded value of USD XX million in 2023, growing with a CAGR of XX% during the forecast period 2024 to 2031. Trocars are crucial instruments in laparoscopic procedures, allowing safe and controlled access to the abdominal cavity. They consist of an obturator for initial puncture, a cannula for subsequent instrument insertion, and a valve mechanism to maintain pneumoperitoneum and prevent gas leakage. Trocars serve as access ports for the insertion of specialized instruments and the insufflation of carbon dioxide gas, which creates pneumoperitoneum (an inflated abdominal space) for better visualization and manipulation of the surgical site. In this technical description, we will delve into the working principles of trocars in laparoscopic procedures.
The production of trocars and their packaging contributed by 70–95% of the impact on the resource endpoint for all three product systems. Similarly, production and packaging were the largest contributors to climate change for all three product systems and represented 60–70% of the impact on this endpoint. The production phase represented 90% of the single-use system’s impact, 65% of the mixed system’s impact, and 35% of the reusable system’s impact on the ecosystem quality endpoint. The sterilization process contributed to 35% of the mixed system’s impact and 65% of the reusable system’s impact on the ecosystem quality endpoint. For all three systems 75–90% of the impact on the human health endpoint came from the production phase. Hence, asp er the above mentioned factors the trocar systems segment is expected to dominate during the forecast period.
Country Analysis
Germany in the Europe Laparoscopy devices market was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period from 2024-2031. Germany in Europe Laparoscopy devices market is expected to hold the largest market share over the forecast period owing to the the factors attributed to the high growth of the region are the increasing number of obesity, along with various chronic diseases, and the growing adoption of minimally-invasive surgeries in the country, strong presence of major players and increasing demand for minimal invasive procedures. About one in eight incident cancers in Germany affects the large intestine (colon) or rectum. Thus, higher the prevalence rate increase the demand for the laproscopic devices.
The projected colorectal cancer cases in Germany are expected to increase significantly over the years 2030, 2040, 2050, and 2060, assuming no changes in colonoscopy utilization levels and sex- and age-specific risks. In 2020, 35,000 men and 27,400 women were newly diagnosed with CRC. For 2030, 2040, 2050, and 2060, these numbers are projected to increase to 39,000 cases in men and 29,400 in women, reflecting an 11-27% (men) and 8-21% (women) higher caseload compared to 2020. Hence, with the rise in the incidence of colorectal cancer in Germany as per the assumed projected data till 2060 there will be a higher demand of the usage of laproscopic devices indeed helping the overall market growth during the forecast period.
Company Share Analysis
The Europe laprscopy devices market is expected to be moderately competitive, owing to the presence of big brands. Also, the market is expanding due to the presence of several large and regional players entering the market. The key players that are contributing to the growth of the global market include B. Braun Melsungen AG, Johnson & Johnson (Ethicon Inc.), Karl Storz GmbH & Co.KG, Medtronic PLC. (Covidien), Olympus Corporation, Richard Wolf GmbH, Stryker Corporation, Aesculap Inc, Intuitive Surgical, Microline Surgical among others. The key players are adopting strategies such as partnerships, mergers, acquisitions and regional expansion to stand out as strong competitors in the market. Novel services and enhanced focus on research and development are other ways the leading players can improve their market presence
